To contentTo navigationTo search
Logotype

Investors

Press releases

Press releases

2021

Implantica publishes Annual Report 2020

24.03.2021
 | Inside information
Implantica AG (publ) is publishing its annual report for the fiscal year 2020. The annual report is now available on the company’s website.

Implantica publicerar årsredovisning 2020

24.03.2021
 | Inside information
Implantica AG (publ) publicerar sin årsredovisning för räkenskapsåret 2020. Årsredovisningen finns nu tillgänglig på bolagets hemsida.

Implantica meddelar att en milstolpe uppnåtts för deras medicinska implantat RefluxStop™

23.03.2021
 | Other press releases
Implantica AG (publ) offentliggör idag att ett av Europas största Universitetssjukhus, AKH Wien, kommer snart påbörja en studie av RefluxStop™ omfattande 25-30 reflux patienter, utförda under ledning av Prof. Dr. med. Sebastian Schoppmann.

Implantica announces a milestone achieved for its implantable medical device RefluxStop™

23.03.2021
 | Other press releases
Implantica AG (publ) today announces that one of the largest hospitals in Europe, University Hospital AKH Vienna, will soon commence a study of RefluxStop™ with 25-30 reflux patients, conducted under the direction of Prof. Dr. med. Sebastian Schoppmann.

Implantica gör framsteg i Italien och Spanien med sitt medicinska implantat RefluxStop ™

15.03.2021
 | Other press releases
Implantica AG (publ) meddelar idag att bolaget kommer börja kommersialisera RefluxStop™ i Italien och Spanien med ersättning av den offentliga sjukvården baserat pa lokala/regonala avtal med sjukhusen.

Implantica makes headway in Italy and Spain with its medical device RefluxStop™

15.03.2021
 | Other press releases
Implantica AG (publ) today announces that the company will start commercializing RefluxStop™ on a reimbursed basis in Italy and Spain based on local/regional hospital agreements.

CEO Peter Forsell presents Implantica at Erik Penser Bank's Bolagsdag

11.03.2021
 | Other press releases
Implantica's CEO Peter Forsell will be joining the Erik Penser Bank's Bolagsdag with an interesting investor presentation.

Implantica advances in Sweden with its medical device RefluxStop™

08.03.2021
 | Other press releases
Implantica AG (publ) today announces that RefluxStop™ will start selling in Sweden with reimbursement by public healthcare.

Implantica’s medicinska implantat RefluxStop ™ tar ett kliv in i den svenska sjukvården

08.03.2021
 | Other press releases
Implantica AG (publ) meddelar idag att RefluxStop ™ kommer lanseras i Sverige med ersättning av offentlig sjukvård.

Implantica publishes Interim Report Q4, January-December 2020

25.02.2021
 | Inside information
“The extraordinary 3-year results of our pivotal RefluxStop™ clinical trial was the highlight of the fourth quarter, with patient data supporting that RefluxStop™ has the attributes to cause a paradigm shift in acid reflux treatment.”
- Peter Forsell, CEO and Founder of Implantica
Load more

This website uses cookies to provide the best possible user experience. If you continue without making any changes you allow this. Read more about cookies here